Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 29, 2012

Conditions

Colchicine Resistant/Intolerant Familial Mediterranean Fever

Interventions

DRUG

Canakinumab

Trial Locations (5)

Rambam Health Care Campus, Haifa

Shaare Zedek Medical Center, Jerusalem

Meir Medical Center Kfar Saba, Kfar Saba

Rabin Medical Center, Petah Tikva

The Chaim Sheba Medical Center, Ramat Gan